Skip to content

GALT - GALECTIN THERAPEUTICS INC - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchG

Galectin Therapeutics Inc

GALT · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

G

GALTGalectin Therapeutics Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $7.13
52-wk low: $2.03
Prev close: $5.16
Mkt cap: $370.1M
Fwd P/E: 4.5x
Beta: 0.35

Smart money

8 funds hold a position and insiders have been net selling.

Real smart money

Funds holding this stock

8 holders

Combined position$23.7M

MW
Marshall Wace
Q2 2026 13F
$3.9M
position
TS
Two Sigma
Q2 2026 13F

Earnings

Reported Aug 13, 2026

Earnings came in $0.05 a share below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Forward P/E: 4.54
Market cap: $370M

Valuation

P/B207.70

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: GALT
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $370.12M
Beta: 0.35

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

207.7x

Profit margin

+0.0%

Op margin

+0.0%

ROE

-3728.0%

$1.5M

position

CI

Citadel

Ken Griffin · Q2 2026 13F

$922K

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for GALT

No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.14-$0.05

-$0.09 expected

Next report

What the street expects next

EPS expected

-$0.05

-$0.05 to -$0.05

Revenue expected

$0.00

1 analysts

Estimate drift

+0.05

Change in 30 days

-3728.0%

ROA-64.2%

Growth

Beta0.35